The Discounted Cash Flow (DCF) valuation of Antares Pharma Inc (ATRS) is 6.80 USD. With the latest stock price at 5.59 USD, the upside of Antares Pharma Inc based on DCF is 21.6%.
Based on the latest price of 5.59 USD and our DCF valuation, Antares Pharma Inc (ATRS) is a buy. buying Antares stocks now will result in a potential gain of 21.6%.
| Range | Selected | |
| WACC / Discount Rate | 7.0% - 9.5% | 8.2% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 5.19 - 10.21 | 6.80 |
| Upside | -7.1% - 82.7% | 21.6% |